spacer
home > ict > spring 2020 > transformational real-world applications
PUBLICATIONS
International Clinical Trials

Transformational Real-World Applications



As part of wider measures to improve patient safety across the EU, the EMA and a range of other stakeholders (from national authorities, pharmaceutical industry brands, and patient advocates to life science IT and service providers) have invested considerable thought, time, and budget into preparing for the region’s implementation of the ISO identification of medicinal products (IDMP) standards over recent years. When this work finally comes to fruition, there will be much gained – not least in bringing new innovation to care and services based on the sharing of reliable, current medicinal information to any interested party internationally.

The goal of IDMP is to build a comprehensive central database of medicinal products that can be readily searched, understood, and relied upon from country to country. Substance, product, organisation, and referential (SPOR) data management services are key to enabling this. Agreed terminology, product definitions, and data formats will enable meaningful data sharing across departmental, organisational, and geographical borders, supporting a wide range of potential use cases – underpinned by a target operating model. This will assess data during the regulatory process to ensure quality and consistency, and optimise the exchange of application data between regulators and applicants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author

Remco Munnik is Associate Director at Iperion, a globally-operating life science consultancy firm that is paving the way to digital healthcare and, as such, strongly committed to contributing to the actual implementation of the ISO IDMP standards.

remco.munnik@iperion.com
Print this page
Send to a friend
Privacy statement
News and Press Releases

Gerresheimer establishes small series production in the USA

Wackersdorf, March 18, 2022: Pharma and medical technology specialist Gerresheimer has established small series production at its Technical Competence Center at its Peachtree City, Georgia location. Small quantities of products can now be manufactured under series conditions and in ISO class 8 cleanroom. During the development and approval of pharmaceutical products and medical devices, this kind of small series is regularly needed for clinical samples or stability batches.
More info >>

White Papers

High-tech Packaging for High-tech Medicine

West Pharmaceutical Services, Inc.

As more biologics and biosimilars come on to the global pharmaceutical market, they can and will present unique packaging and containment challenges. For materials that are sensitive to glass or that may require larger-dose volumes or custom configurations, cyclic olefin polymers may offer a solution. These novel materials for drug container closure systems can provide a needed alternative to traditional glass containment systems for advanced therapeutics.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement